Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | RGS12 | O14924 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 6/20 | 0.31 |
| ▸ | MAOA | P21397 | 3/20 | 0.31 |
| ▸ | EGFR | P00533 | 2/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27750433 | 1.00 | KDM1A (0.34) | KDM1ARCOR1ALDH1A1TDP1MEN1 | |
| SCHEMBL4096847 | 0.84 | KDM1A (0.43) | KDM1ARCOR1ALDH1A1TDP1MEN1 | |
| SCHEMBL4095120 | 0.83 | MAOB (0.41) | KDM1AMAOBMAOAEGFRKCNH2 | |
| SCHEMBL4082596 | 0.77 | SLC6A2 (0.36) | ALDH1A1MEN1RGS12CYP3A4KMT2A | |
| SCHEMBL4096980 | 0.74 | ALDH1A1 (0.39) | KDM1AALDH1A1TDP1CYP3A4MAOB | |
| SCHEMBL23795263 | 0.73 | MAPT (0.35) | ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL4083002 | 0.72 | SLC6A4 (0.41) | KDM1ARCOR1CYP3A4 | |
| SCHEMBL4099398 | 0.63 | SLC6A3 (0.39) | KDM1AALDH1A1TDP1MEN1CYP3A4 | |
| SCHEMBL26378418 | 0.61 | MEN1 (0.50) | ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL4082808 | 0.61 | CCR2 (0.42) | KDM1AALDH1A1MEN1RGS12CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100512582-C | Light emitting system, light emitting method and chemical substance for light emission | HITACHI CHEMICAL CO LTD (JP) | 2009-07-08 | — | — | CN | disclosed |
| US-20090163743-A1 | LUMINESCENCE SYSTEM, METHOD OF LUMINESCENCE, AND CHEMICAL SUBSTANCE FOR LUMINESCENCE | HOSHI YOUSUKE | 2009-06-25 | — | — | US | disclosed |
| US-20070138945-A1 | Luminescence system, method of luminescence, and chemical substance for luminescence | HITACHI CHIEMICAL CO., LTD., (JP) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070138945-A1 | Luminescence system, method of luminescence, and chemical substance for luminescence | GLO1, TYR, GUSB | KDM1A 3827/4885RCOR1 3332/4885ALDH1A1 48/4885 |
| US-20090163743-A1 | LUMINESCENCE SYSTEM, METHOD OF LUMINESCENCE, AND CHEMICAL SUBSTANCE FOR LUMINESCENCE | GLO1, TYR, GUSB | KDM1A 3827/4885RCOR1 3332/4885ALDH1A1 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.